Skip to main content
Top

Journal of Radiation Oncology

Issue 2/2019

Content (14 Articles)

Gallbladder Cancer Original Research

Adjuvant chemoradiation in resected gallbladder cancer: a prognostic index model for predicting overall survival

Claudio V. Sole, Lorena Vargas, Vicente J. Sole, Francisco Larsen, Sebastian Sole

NSCLC Original Research

Lymphopenia as a predictor of survival in chemoradiation-treated stage III non-small-cell lung cancer (NSCLC): a multi-center retrospective analysis

Vidhya Karivedu, Rishi Agarwal, Sulsal Ul Haque, Bicky Thapa, Farhad Fakhrejahani, Pingfu Fu, Gregory M. M. Videtic, Nooshin Hashemi Sadraei

Prostate Cancer Original Research

Changes in prostate-specific antigen midway through salvage radiotherapy may be associated with long-term outcomes

Jason M. Homza, John T. Nawrocki, Harmar D. Brereton, Christopher A. Peters

Original Research

Whiteboard patient tracking system improves radiation oncology treatment planning workflow

Christopher Freese, Neil Forster, Brittany Prater, Meredith Amlung, Michael Lamba, Vinita Takiar

Computed Tomography Original Research

Fast in situ image reconstruction for proton radiography

Caesar E. Ordoñez, Nicholas T. Karonis, Kirk L. Duffin, John R. Winans, Ethan A. DeJongh, Don F. DeJongh, George Coutrakon, Nicole F. Myers, Mark Pankuch, James S. Welsh

Ionizing Radiation Original Research

Effect of intermittent low-dose irradiation on the radiotherapy efficiency for MDA-MB-231 human breast adenocarcinoma cell line

Amir Danyaei, Hashem Khanbabaei, Ali Teimoori, Mohammad Javad Tahmasbi, Hojattollah Shahbazian, Halime Mansoury Asl

Lung Cancer Original Research

A risk model for lung complication combining radiation therapy and chronic obstructive pulmonary disease

Roman O. Kowalchuk, Daniel M. Trifiletti, Shiv R. Khandelwal, James M. Larner, W. Tyler Watkins

Prostate Cancer Original Research

Salvage radiation therapy following radical prostatectomy in Stockholm County in 2008–2016

Jens Falk, Markus Aly, Anders Berglund, Tobias Nordström, Alexander Valdman

Lung Cancer Original Research

Stereotactic body radiotherapy versus conventional radiotherapy for early-stage small cell lung cancer

Neil B. Newman, Alexander D. Sherry, Daniel W. Byrne, Evan C. Osmundson

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine